{"organizations": [], "uuid": "6980fc71d0bcfb875e41a10b4c155d3b192d74ce", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180305.html", "section_title": "Archive News &amp; Video for Monday, 05 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-quantum-genomics-launches-equity-l/brief-quantum-genomics-launches-equity-line-financing-with-kepler-cheuvreux-idUSFWN1QN0Q9", "country": "US", "domain_rank": 408, "title": "BRIEF-Quantum Genomics Launches Equity Line Financing With Kepler Cheuvreux", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-03-06T02:33:00.000+02:00", "replies_count": 0, "uuid": "6980fc71d0bcfb875e41a10b4c155d3b192d74ce"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-quantum-genomics-launches-equity-l/brief-quantum-genomics-launches-equity-line-financing-with-kepler-cheuvreux-idUSFWN1QN0Q9", "ord_in_thread": 0, "title": "BRIEF-Quantum Genomics Launches Equity Line Financing With Kepler Cheuvreux", "locations": [], "entities": {"persons": [{"name": "kepler cheuvreux", "sentiment": "negative"}, {"name": "kepler", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 5 (Reuters) - QUANTUM GENOMICS SA:\n* SECURES OPERATIONAL FLEXIBILITY AND GROWTH CAPITAL THROUGH EQUITY LINE FINANCING WITH KEPLER CHEUVREUX\n* ANNOUNCES IMPLEMENTATION OF EQUITY LINE FINANCING FACILITY, CAPPED AT EUR 24 MLN OVER A THREE-YEAR PERIOD, STRUCTURED AND BACKED BY KEPLER CHEUVREUX\n* EQUITY FINANCING PLAN WILL BEGIN WITH A EUR 6 MILLION TRANCHE STARTING 5 MARCH 2018â€‹\n* RECRUITMENT FOR NEW-HOPE, A PHASE II CLINICAL STUDY IN TREATING HYPERTENSION, FASTER THAN PROJECTED\n* TARGET PATIENT PROFILE IN QUID HF, A PHASE IIA CLINICAL STUDY IN TREATING HEART FAILURE, WIDENED Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-06T02:33:00.000+02:00", "crawled": "2018-03-06T22:06:11.015+02:00", "highlightTitle": ""}